Interleukin‐6–174 G/C Promoter Gene Polymorphism C Allele Reduces Alzheimer's Disease Risk
Open Access
- 26 March 2003
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 51 (4) , 578-579
- https://doi.org/10.1046/j.1532-5415.2003.51177.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitroGlia, 2001
- Physiology and biochemistry of the interleukin-6 receptor complex: Implications for CNS disorders and Alzheimer’s diseasePublished by Springer Nature ,2001
- Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's diseaseNeuroscience Letters, 2000
- Inflammation and Alzheimer's diseaseNeurobiology of Aging, 2000
- Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German populationNeuroscience Letters, 2000
- A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's diseaseAnnals of Neurology, 1999
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.Journal of Clinical Investigation, 1998
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984